164 related articles for article (PubMed ID: 29162047)
1. Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
Otte I; Salloch S; Reinacher-Schick A; Vollmann J
BMC Cancer; 2017 Nov; 17(1):780. PubMed ID: 29162047
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of an evidence-based clinical practice guideline in cancer pain management by medical oncologists: a case vignette study.
te Boveldt N; Vernooij-Dassen M; Besse K; Vissers K; Engels Y
Support Care Cancer; 2015 May; 23(5):1409-20. PubMed ID: 25370888
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
[TBL] [Abstract][Full Text] [Related]
4. Who should provide care for patients receiving palliative chemotherapy? A qualitative study among Dutch general practitioners and oncologists.
Wind J; Nugteren IC; van Laarhoven HWM; van Weert HCPM; Henselmans I
Scand J Prim Health Care; 2018 Dec; 36(4):437-445. PubMed ID: 30375906
[TBL] [Abstract][Full Text] [Related]
5. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
[TBL] [Abstract][Full Text] [Related]
6. Exploration of oncologists' attitudes toward and perceived value of patient-reported outcomes.
Meldahl ML; Acaster S; Hayes RP
Qual Life Res; 2013 May; 22(4):725-31. PubMed ID: 22684493
[TBL] [Abstract][Full Text] [Related]
7. Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
Naeim A; Wong FL; Pal SK; Hurria A
Clin Breast Cancer; 2010 Apr; 10(2):136-43. PubMed ID: 20353934
[TBL] [Abstract][Full Text] [Related]
8. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
[TBL] [Abstract][Full Text] [Related]
11. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
[TBL] [Abstract][Full Text] [Related]
12. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario.
Graham ID; Evans WK; Logan D; O'Connor A; Palda V; McAuley L; Brouwers M; Harrison MB
Oncology; 2000 Nov; 59(4):283-90. PubMed ID: 11096339
[TBL] [Abstract][Full Text] [Related]
13. What does physicians' clinical expertise contribute to oncologic decision-making? A qualitative interview study.
Salloch S; Otte I; Reinacher-Schick A; Vollmann J
J Eval Clin Pract; 2018 Feb; 24(1):180-186. PubMed ID: 29076629
[TBL] [Abstract][Full Text] [Related]
14. Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.
Zhou N; Zhang CT; Lv HY; Hao CX; Li TJ; Zhu JJ; Zhu H; Jiang M; Liu KW; Hou HL; Liu D; Li AQ; Zhang GQ; Tian ZB; Zhang XC
Oncologist; 2019 Jun; 24(6):812-819. PubMed ID: 30181315
[TBL] [Abstract][Full Text] [Related]
15. "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.
Schildmann J; Tan J; Salloch S; Vollmann J
Oncologist; 2013; 18(1):90-6. PubMed ID: 23287883
[TBL] [Abstract][Full Text] [Related]
16. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
[No Abstract] [Full Text] [Related]
17. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.
Davda R; Hughes S; Jones R; Crabb SJ; Troup J; Payne H
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):376-85. PubMed ID: 26874654
[TBL] [Abstract][Full Text] [Related]
18. [Physician perspectives on the impact of patient preferences and the role of next-of-kin of patients in evidence-based decision-making: A qualitative interview study from oncology].
Salloch S; Otte IC; Reinacher-Schick A; Vollmann J
Z Evid Fortbild Qual Gesundhwes; 2018 Apr; 131-132():46-52. PubMed ID: 29544714
[TBL] [Abstract][Full Text] [Related]
19. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
20. Differences in pediatric oncologists' estimates of curability and treatment recommendations for patients with advanced cancer.
Wusthoff CJ; McMillan A; Ablin AR
Pediatr Blood Cancer; 2005 Feb; 44(2):174-81. PubMed ID: 15390284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
